Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Yaounde Central Hospital, Yaoundé, Cameroon.
Pan Afr Med J. 2023 Aug 21;45:173. doi: 10.11604/pamj.2023.45.173.38466. eCollection 2023.
Community-based organizations (CBOs) are one of the initiatives implemented in Cameroon to improve access to antiretroviral treatment and influence retention in treatment centers. Despite its importance in the decongestion of patients in health facilities, we do not have data to evaluate the overall impact of these organizations. We conducted a two-part observational study. The first part was a descriptive cross-sectional study, where we included patients screened and initiated on anti-retroviral treatment (ART) either by the approved Treatment center (ATC) of Yaoundé Central Hospital (YCH) or by any of our CBOs in 2020. Then, the second part was a retrospective cohort-type study including patients from the 2015 cohort followed up from 2018 to 2020 in order to assess viral load suppression. As regards the first "90", 7,234 screening tests were performed by CBOs in 2020 out of the 28,302 screening tests registered at the YCH, giving a contribution of 25.6%. From the 7,234 screening tests performed by CBOs, 314 people had an HIV-positive result and 230 (73.34%) were linked to ART through CBOs. From the 28,302 screening tests performed at YCH, 1,089 people had an HIV-positive test, and only 354 (32.50%) were linked to ART, giving a significant difference in the link to ART (P-value < 0.00). Concerning the 3 ''90'', the viral load suppression rates were respectively in CBOs and at YCH of (95.12% vs 90.54%, RR= 0.51; P-value= 0.27 at 12 months); (95.96% vs 95.34%, relative risk (RR)= 0.85; P-value= 0.81 at 24 months); and (96.91% vs 94.15%, RR= 0.52; P-value = 0.24 at 36 months). In conclusion, we say that the follow-up of patients living with HIV in the community does not negatively affect the evolution of the disease as one might think.
社区组织(CBOs)是喀麦隆为改善获得抗逆转录病毒治疗的机会和影响治疗中心保留率而实施的举措之一。尽管它们在减轻卫生机构中患者拥挤方面很重要,但我们没有数据来评估这些组织的总体影响。我们进行了一项两部分的观察性研究。第一部分是描述性的横断面研究,其中包括 2020 年在雅温得中央医院(YCH)批准的治疗中心或我们的任何一个 CBO 接受抗逆转录病毒治疗(ART)筛选和启动的患者。然后,第二部分是回顾性队列研究,包括 2015 年队列中从 2018 年到 2020 年随访的患者,以评估病毒载量抑制情况。关于第一个“90”,2020 年 CBO 进行了 7234 次筛查测试,而 YCH 登记的筛查测试为 28302 次,占 25.6%。在 CBO 进行的 7234 次筛查测试中,有 314 人 HIV 检测呈阳性,其中 230 人(73.34%)通过 CBO 链接到抗逆转录病毒治疗。在 YCH 进行的 28302 次筛查测试中,有 1089 人 HIV 检测呈阳性,只有 354 人(32.50%)链接到抗逆转录病毒治疗,这表明链接到抗逆转录病毒治疗的差异有统计学意义(P 值<0.00)。关于第三个“90”,病毒载量抑制率分别在 CBO 和 YCH 为(95.12% 对 90.54%,RR=0.51;P 值=0.27,12 个月);(95.96% 对 95.34%,相对风险(RR)=0.85;P 值=0.81,24 个月);和(96.91% 对 94.15%,RR=0.52;P 值=0.24,36 个月)。总之,我们可以说,在社区中对艾滋病毒感染者的随访不会像人们想象的那样对疾病的发展产生负面影响。